Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Reichardt

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Blood|October 26, 2000
Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cellsP Brossart, S Wirths, G Stuhler, et al.
Haematologica|October 14, 2003
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cellsVolker L Reichardt, Caterina Milazzo, Wolfram Brugger, et al.
Blood|January 15, 2000
Induction of minor histocompatiblity antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantationP Brossart, B Spahlinger, F Grünebach, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myelomaV L Reichardt, C Y Okada, K E Stockerl-Goldstein, et al.
The Journal of Cell Biology|March 1, 1996
Cloning of mouse integrin alphaV cDNA and role of the alphaV-related matrix receptors in metanephric developmentJ Wada, A Kumar, Z Liu, et al.
Developmental Biology|June 8, 1999
NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursorsN Francis, I Farinas, C Brennan, et al.
Blood|December 3, 1998
Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorP Brossart, F Grünebach, G Stuhler, et al.
Cancer Research|September 2, 2000
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsP Brossart, A Zobywalski, F Grünebach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignanciesA du Bois, J Huober, P Stopfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2010
An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumorsRalf-Dieter Hofheinz, Salah-Eddin Al-Batran, Andreas Hochhaus, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Blood|October 26, 2000
Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cellsP Brossart, S Wirths, G Stuhler, et al.
Haematologica|October 14, 2003
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cellsVolker L Reichardt, Caterina Milazzo, Wolfram Brugger, et al.
Blood|January 15, 2000
Induction of minor histocompatiblity antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantationP Brossart, B Spahlinger, F Grünebach, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myelomaV L Reichardt, C Y Okada, K E Stockerl-Goldstein, et al.
The Journal of Cell Biology|March 1, 1996
Cloning of mouse integrin alphaV cDNA and role of the alphaV-related matrix receptors in metanephric developmentJ Wada, A Kumar, Z Liu, et al.
Developmental Biology|June 8, 1999
NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursorsN Francis, I Farinas, C Brennan, et al.
Blood|December 3, 1998
Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorP Brossart, F Grünebach, G Stuhler, et al.
Cancer Research|September 2, 2000
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsP Brossart, A Zobywalski, F Grünebach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignanciesA du Bois, J Huober, P Stopfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2010
An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumorsRalf-Dieter Hofheinz, Salah-Eddin Al-Batran, Andreas Hochhaus, et al.
Pageof 4